Benzinga | Aug 17, 2021 12:05PM EDT

Cowen & Co. Initiates Coverage On Cytek Biosciences with Outperform Rating

Cowen & Co. analyst Max Masucci initiates coverage on Cytek Biosciences (NASDAQ:CTKB) with a Outperform rating.